RU2002101613A -
A method for the correction of immuno-and hepatotoxic effects of cyclophosphamide
- Google Patents
A method for the correction of immuno-and hepatotoxic effects of cyclophosphamide
Info
Publication number
RU2002101613A
RU2002101613ARU2002101613/14ARU2002101613ARU2002101613ARU 2002101613 ARU2002101613 ARU 2002101613ARU 2002101613/14 ARU2002101613/14 ARU 2002101613/14ARU 2002101613 ARU2002101613 ARU 2002101613ARU 2002101613 ARU2002101613 ARU 2002101613A
150000003712vitamin E derivativesChemical class0.000claims1
Claims (1)
Способ коррекции иммуно- и гепатотоксических эффектов циклофосфана, включающий введение лекарственных средств, отличающийся тем, что вводят витамин Е перорально в дозе 5 МЕ/мышь троекратно с интервалом 48 ч, а Тактивин в дозе 0,25 мг/кг внутримышечно ежедневно в течение 5 дней.A method for correcting the immuno-and hepatotoxic effects of cyclophosphamide, including the administration of drugs, characterized in that vitamin E is administered orally at a dose of 5 IU / mouse three times with an interval of 48 hours, and Tactivin at a dose of 0.25 mg / kg intramuscularly daily for 5 days .
RU2002101613/14A2002-01-24
A method for the correction of immuno-and hepatotoxic effects of cyclophosphamide
RU2002101613A
(en)
antiretroviral pharmaceutical composition, process for the preparation of an antiretroviral pharmaceutical composition, method for reducing the burden of pill consumption for a patient, method for increasing lamivudine and zidovudine half-life while not affecting nevirapine half-life